Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9G3L

LecB from PA01 in complex with synthetic beta - fucosylamide

This is a non-PDB format compatible entry.
Summary for 9G3L
Entry DOI10.2210/pdb9g3l/pdb
DescriptorFucose-binding lectin PA-IIL, CALCIUM ION, 5-[3-(aminomethyl)phenyl]-~{N}-[(2~{S},3~{S},4~{R},5~{S},6~{S})-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]furan-2-carboxamide, ... (5 entities in total)
Functional Keywordslectin, beta-fucosylamide, anti-adhesive, pseudomonas, sugar binding protein
Biological sourcePseudomonas aeruginosa PAO1
Total number of polymer chains4
Total formula weight48540.77
Authors
Antonini, G.,Varrot, A. (deposition date: 2024-07-12, release date: 2025-04-16, Last modification date: 2025-05-21)
Primary citationAntonini, G.,Fares, M.,Hauck, D.,Mala, P.,Gillon, E.,Belvisi, L.,Bernardi, A.,Titz, A.,Varrot, A.,Mazzotta, S.
Toward Dual-Target Glycomimetics against Two Bacterial Lectins to Fight Pseudomonas aeruginosa - Burkholderia cenocepacia Infections: A Biophysical Study.
J.Med.Chem., 68:9681-9693, 2025
Cited by
PubMed Abstract: Chronic lung infections caused by and pose a severe threat to immunocompromised patients, particularly those with cystic fibrosis. These pathogens often infect the respiratory tract, and available treatments are limited due to antibiotic resistance. Targeting bacterial lectins involved in biofilm formation and host-pathogen interactions represents a promising therapeutic strategy. In this study, we evaluate the potential of synthetic fucosylamides as inhibitors of the two lectins LecB () and BC2L-C-Nt (). Using a suite of biophysical assays, we assessed their binding affinities, identifying three β-fucosylamides as promising dual-target ligands, while crystallography studies revealed the atomic basis of these ligands to interact with both bacterial lectins. The emerged classes of compounds represent a solid starting point for the necessary hit-to-lead optimization for future dual inhibitors aiming at the treatment of coinfections with these two bacterial pathogens.
PubMed: 40279549
DOI: 10.1021/acs.jmedchem.5c00405
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.739 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon